Podcasts

Episode 10 | Long Term Survivorship: Thriving with Metastatic Lung Cancer

In this episode, Lillian Leigh, Dr Sarah Heynemann and Mary Duffy discuss the challenges associated with long term survivorship.

Long Term Survivorship: Thriving with Metastatic Lung Cancer

Episode Summary

In this episode, Lillian Leigh, Dr Sarah Heynemann and Mary Duffy discuss the challenges associated with long term survivorship.

This TOGA Podcast focuses on thriving with lung cancer and overcoming the challenges associated with long term survivorship and lung cancer. The past decade has seen significant advances in the management of metastatic NSCLC with the advent of multiple targeted therapies, immunotherapy approaches and combination approaches and associated improvements in survival outcomes for patients. There is an emerging cohort of patients with advanced NSCLC who experience long periods of disease control whilst on these treatments.

Traditionally survivorship has referred to the care of or issues for patients following curative treatment of early-stage disease. However, due to the recent advances described here, there is a compelling need to begin addressing the issues faced by long term metastatic disease ’survivors’.

Show Hosts

This episode’s host are:

  • Lillian Leigh, Membership and Advocacy Chair, TOGA; long-term survivor of lung cancer
  • Dr Sarah Heynemann, Medical Oncologist
  • Mary Duffy, Lung Cancer Clinical Nurse Consultant, Lung MDT, Peter MacCallum Cancer Institute

Play Episode 10 | Long Term Survivorship: Thriving with Metastatic Lung Cancer

More Podcasts

Host A/Prof Steven Kao is joined by A/Prof Venessa Chin and Dr Ben Kong,
Host A/Prof Mel Moore interviews Prof Zarnie Lwin OAM, University of Queensland; Medical Oncologist at Royal Brisbane and Women’s Hospital and The Prince Charles Hospital.
A/Prof Gavin Wright sits down with a multidisciplinary panel of experts to tackle the critical and complex issue of smoking-related stigma in lung cancer.
Host A/Prof Mel Moore interviews Dr Jazmin Eckhaus, a practising surgeon in the subspecialty of thoracic surgery.
Host A/Prof Adnan Nagrial leads a panel discussing the clinical implications of the broad PBS listing of ipilimumab and nivolumab in Australia.
Host A/Prof Deme Karikios leads a panel discussion focusing on the recent, groundbreaking broad PBS listing of certain immunotherapy agents in Australia.